LISATA THERAPEUTICS, INC. Repayments of Related Party Debt
LISATA THERAPEUTICS, INC. (LSTA) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2013-03-11
- LISATA THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2012-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2012-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2012-06-30 was -$34.67K.
- LISATA THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2012-03-31 was $34.67K, a 98.84% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of related party debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- LISATA THERAPEUTICS, INC. repayments of related party debt for fiscal 2011 was $3.00M.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 6 month as first filed | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 9 month as first filed | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 derived: sum of 2 quarters · filed 2013-03-11 | -$34.67K derived: sum of 3 quarters · filed 2013-03-11 | $0.00 10-K · filed 2013-03-11 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$34.67K derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2012-06-30 | -$34.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-11 | $0.00 derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2012-03-31 | $34.67K 10-Q · filed 2012-05-11 | $34.67K derived: sum of 2 quarters · filed 2013-03-11 | $34.67K derived: sum of 3 quarters · filed 2013-03-11 | $34.67K derived: sum of 4 quarters · filed 2013-03-11 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $0.00 derived: sum of 2 quarters · filed 2013-03-11 | $0.00 derived: sum of 3 quarters · filed 2013-03-11 | $3.00M 10-K · filed 2013-03-11 | $3.53M 10-K · filed 2012-03-20 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $3.00M 10-Q · filed 2012-11-13 | $3.41M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $3.00M 10-Q · filed 2012-08-14 | $3.41M 10-Q · filed 2011-08-12 | ||||
| 2011-03-31 | $3.00M 10-Q · filed 2012-05-11 | ||||||
| 2010-12-31 | $0.00 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |